Overview
ISO 24480:2024 - Biotechnology - Validation of database used for nucleotide sequence evaluation provides a practical, minimum-requirements procedure for validating nucleotide sequence databases intended for sequence-evaluation tasks. The standard applies only to databases that consist of nucleotide sequence entries (not to full database quality assessments of every individual entry). Its focus is ensuring databases are fit-for-purpose when used to evaluate sequence specificity for oligonucleotides (primers/probes) and other nucleotide-based assays.
Key Topics
- Scope and applicability: validation procedure for databases of nucleotide sequences; not a general per-entry quality audit.
- Two validation roles
- Inclusivity database - must cover intended target sequences and contain reliably annotated, representative entries for sensitivity/inclusivity analysis.
- Exclusivity database - should contain a broad range of related and unrelated sequences to detect potential non-specific hybridization.
- Quality criteria and data indicators: provenance and update history, entry length, number of unidentified nucleotides (Ns), and other metadata used to assess database fitness.
- Validation process and reporting: requirements for documenting validation activities and producing a validation report suitable for inclusion in diagnostic/surveillance method validation.
- Practical tools and examples: guidance refers to in‑silico similarity searches (e.g., BLAST), handling NGS/NGS-derived data sets, and includes informative annexes with example data formats and validation workflows.
- Terminology: defines key terms (inclusivity, exclusivity, sequence similarity, representative/undesirable sequences) to support consistent implementation.
Applications
ISO 24480:2024 is intended for organizations and professionals who perform or rely on nucleotide sequence evaluation:
- Assay developers designing primers/probes for PCR, qPCR, dPCR, and microarray assays.
- Clinical, veterinary and environmental diagnostic laboratories validating molecular tests and surveillance pipelines.
- Biotech and pharmaceutical companies using sequence databases for target confirmation or assay specificity checks.
- Reference laboratories and regulators assessing the adequacy of database-driven in‑silico evaluations as part of method validation.
Validated databases per ISO 24480 can be integrated into validated diagnostic or surveillance methods to improve confidence in sequence specificity, selectivity and overall assay performance.
Related Standards
- ISO 20691 - Requirements for data formatting and description in the life sciences (normative reference).
- Referenced terminology and related guidance: ISO/TS 23494‑1, ISO 16577, ISO 20813 (see ISO 24480:2024 bibliography and normative references for details).
Keywords: ISO 24480:2024, nucleotide sequence database validation, inclusivity, exclusivity, primer specificity, qPCR, dPCR, PCR, microarray, BLAST, database provenance, NGS.
